SPRY - ARS Pharmaceuticals Inc
IEX Last Trade
12.96
-0.020 -0.154%
Share volume: 946,823
Last Updated: Fri 30 Aug 2024 09:59:59 PM CEST
Research and Development in Biotechnology (except Nanobiotechnology):
0.21%
PREVIOUS CLOSE
CHG
CHG%
$12.98
-0.02
-0.15%
Fundamental analysis
24%
Profitability
25%
Dept financing
1%
Liquidity
75%
Performance
15%
Performance
5 Days
0.15%
1 Month
18.32%
3 Months
45.68%
6 Months
43.90%
1 Year
82.56%
2 Year
146.77%
Key data
Stock price
$12.96
DAY RANGE
N/A - N/A
52 WEEK RANGE
$2.55 - $16.50
52 WEEK CHANGE
$0.83
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
11/07/2024
Company detail
CEO:
Region: US
Website: silverbacktx.com
Employees: 20
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry: Research and Development in Biotechnology (except Nanobiotechnology)
Sector: Professional, Scientific, and Technical Services
Region: US
Website: silverbacktx.com
Employees: 20
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry: Research and Development in Biotechnology (except Nanobiotechnology)
Sector: Professional, Scientific, and Technical Services
silverback therapeutics is a biotechnology company that was founded in 2016. the company is based in seattle, wa and is funded by orbimed.
Recent news